Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OIC-16009157Phase 4Recruiting
Phase 4, open-label trial of vecuronium (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Clinical effect time of vecuronium, Index of recovery and 2 more. Started Sep 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OIC-16009157.